Bloomberg Market Wrap 5/14: Macy's, Biotech Stocks, S&P Hedging

The video discusses Macy's recent stock performance, highlighting its recovery from a losing streak and upcoming earnings report. It also covers the biotech sector's potential for a rally, driven by low earnings expectations and cheap valuations. Analysts highlight companies like United Therapeutics and Gilead. The video concludes with insights from a Bank of America Fund Manager survey, revealing that many fund managers have not taken protection against market falls, despite trade war concerns.

What key metric is important to watch in Macy's upcoming earnings report?

• Margins

• Market share

• Stock price

• Revenue growth

Which factor is NOT mentioned as affecting Macy's margins?

• Weather conditions

• New product launches

• Seasonal factors

• Rising labor costs

What is the expected outcome for the biotech sector according to Oppenheimer analysts?

• A decline in stock prices

• A rally in the back half of the year

• Stable performance

• Increased regulatory challenges

Which company is NOT mentioned as a potential beneficiary in the biotech sector?

• Pfizer

• Vertex Pharmaceuticals

• Gilead

• United Therapeutics

What is the main concern for investors according to the Bank of America survey?

• Interest rate hikes

• Corporate tax changes

• Trade wars

• Inflation